Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.
Saved in:
| Title: | Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions. |
|---|---|
| Authors: | Geretti, Anna Maria1,2,3 (AUTHOR), Boffito, Marta4 (AUTHOR), Bonora, Stefano5 (AUTHOR), Braun, Patrick6,7 (AUTHOR), Charpentier, Charlotte8,9 (AUTHOR), Garcia, Federico10,11,12 (AUTHOR), Ghosn, Jade13,14 (AUTHOR), Gomes, Perpetua15,16 (AUTHOR), Marcelin, Anne-Geneviève17 (AUTHOR), Mesplède, Thibault18 (AUTHOR), Parczewski, Milosz19 (AUTHOR), Ring, Kyle20,21 (AUTHOR), Santoro, Maria Mercedes22 (AUTHOR), Solas, Caroline23,24 (AUTHOR), Wolf, Eva25,26 (AUTHOR), Orkin, Chloe20,21 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. Jul2025, Vol. 12 Issue 7, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23288957 |
|---|---|
| DOI: | 10.1093/ofid/ofaf368 |